SAR-020106 CAS:1184843-57-9
SAR-020106  
						| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product | 
|---|---|---|---|---|
| R-C-2501 | 10mg | 245.00 | + Add to cart  | 
																					|
| R-C-2501 | 25mg | 525.00 | + Add to cart  | 
																					|
| R-C-2501 | 50mg | 800.00 | + Add to cart  | 
																					|
| 
										 | 
								||||
Product description
							SAR-020106 is an ATP-competitive,potent,and selective CHK1 inhibitor with an IC50 of 13.3nM for human CHK1.SAR-020106 shows excellent selectivity over CHK2.SAR-020106 significantly enhances the cell killing of Gemcitabine and SN38 by 3-to 29-fold in several colon tumor lines and in a p53-dependent fashion.SAR-020106 can enhance antitumor activity with selected anticancer drugs.
								| Appearance | N/A | 
|---|---|
| Molecular Weight | N/A | 
| purity | >95% | 
| PDI by GPC | <1.5 | 
| Solubility | N/A | 
| Storage | -20℃, protected from light and moisture | 
| Transportation | 4-25℃ temperature for up to 3 weeks | 
| Stability | 2 years | 
Document
							Related Product
							
						
Items-$0.00

Email:
Tel.:
msds---SAR-020106   
                    RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                
                    Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China 
                
                    Tel:  02988811435
                
                    Fax: (86-29)8881-1435
                
                    Email: sales@ruixibiotech.com
                
                    Web: http://www.ruixibiotech.com    
					
							
                

